natgillin/translations-raw huggingface dataset:
That assessment was based on the results of an inspection carried out by experts of the European Maritime Safety Agency in December 2009.
Ocena je temeljila na rezultatih inšpekcije, ki so jo decembra 2009 opravili izvedenci Evropske agencije za pomorsko varnost.
on the recognition of Uruguay pursuant to Directive 2008/106/EC of the European Parliament and of the Council as regards the systems for the training and certification of seafarers
o priznanju Urugvaja v skladu z Direktivo 2008/106/ES Evropskega parlamenta in Sveta glede sistemov za izobraževanje in izdajanje spričeval pomorščakom
Having regard to the request from Spain on 14 February 2006,
ob upoštevanju prošnje Španije dne 14. februarja 2006,
By letters of 16 February 2009 and 8 December 2010, the Commission requested Uruguay to provide evidence demonstrating that the deficiencies identified had been corrected.
Komisija je z dopisoma z dne 16. februarja 2009 in 8. decembra 2010 od Urugvaja zahtevala predložitev dokazov, da so bile odkrite pomanjkljivosti odpravljene.
By letters of 30 April 2009 and 18 March 2011, Uruguay provided the requested information and evidence concerning the implementation of appropriate and sufficient corrective action to address most of the deficiencies identified during the assessment of compliance.
Urugvaj je v dopisih z dne 30. aprila 2009 in 18. marca 2011 predložil zahtevane informacije in dokaze glede izvajanja ustreznih in zadostnih korektivnih ukrepov, s katerimi se obravnava večina pomanjkljivosti, ki so bile ugotovljene med oceno skladnosti.
The first refers to the fact that the quality standards system does not cover some of the activities of the administration, such as the approval of training programmes.
Prva se nanaša na dejstvo, da sistem standardov kakovosti ne zajema nekaterih dejavnosti uprave, kot je odobritev izobraževalnih programov.
The other shortcoming relates to the format of certificates.
Druga pomanjkljivost se nanaša na obliko spričeval.
Uruguay has therefore been invited to implement further corrective actions in this respect.
Urugvaj je bil pozvan, naj na tem področju nadaljuje z izvajanjem korekcijskih ukrepov.
However, these shortcomings do not warrant calling into question the overall level of compliance of Uruguay with STCW requirements on training and certification of seafarers.
Vendar te pomanjkljivosti ne upravičujejo dvomov v vsesplošno raven upoštevanja zahtev Konvencije STCW glede sistemov izobraževanja in izdajanja spričeval za pomorščake s strani Urugvaja.
The outcome of the assessment of compliance and the evaluation of the information provided by Uruguay demonstrates that Uruguay complies with the relevant requirements of the STCW Convention, while this country has taken appropriate measures to prevent fraud involving certificates.
Izid ocene skladnosti in ocena informacij, ki jih je predložil Urugvaj, kažeta, da ta država izpolnjuje vse zahteve Konvencije STCW in da je sprejela vse ustrezne ukrepe za preprečevanje goljufij v zvezi s spričevali.
For the purposes of Article 19 of Directive 2008/106/EC, Uruguay is recognised as regards the systems for the training and certification of seafarers.
Urugvaj se prizna za namene člena 19 Direktive 2008/106/ES glede sistemov za izobraževanje in izdajanje spričeval pomorščakom.
The request for the recognition of Uruguay was submitted by Spain by letter of 14 February 2006.
Španija je z dopisom z dne 14. februarja 2006 zaprosila za priznanje Urugvaja.
Following this request, the Commission assessed the training and certification system in Uruguay in order to verify whether Uruguay meets all the requirements of the STCW Convention and whether the appropriate measures have been taken to prevent fraud involving certificates.
Na podlagi te prošnje je Komisija ocenila sisteme za izobraževanje in izdajanje spričeval v Urugvaju, da bi preverila, ali ta država izpolnjuje zahteve Konvencije STCW in ali so bili sprejeti ustrezni ukrepi za preprečevanje goljufij, povezanih s spričevali.
That assessment was based on the results of an inspection carried out by experts of the European Maritime Safety Agency in June 2007.
Ocena je temeljila na rezultatih inšpekcije, ki so jo junija 2007 opravili izvedenci Evropske agencije za pomorsko varnost.
concerning the non-inclusion of flufenoxuron for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market
o nevključitvi flufenoksurona za 18. vrsto izdelkov v Prilogo I, IA ali IB k Direktivi 98/8/ES Evropskega parlamenta in Sveta o dajanju biocidnih pripravkov v promet
That list includes flufenoxuron.
Navedeni seznam vključuje flufenoksuron.
Pursuant to Regulation (EC) No 1451/2007, flufenoxuron (CAS No 101463-69-8; EC No 417-680-3) has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product type 18, insecticides, acaricides and products to control other arthropods, as defined in Annex V to that Directive.
Na podlagi Uredbe (ES) št. 1451/2007 je bila v skladu s členom 11(2) Direktive 98/8/ES opravljena presoja flufenoksurona (št. CAS 101463-69-8; št. ES 417-680-3) glede uporabe v 18. vrsti izdelkov, insekticidih, akaricidih in pripravkih za nadzor drugih členonožcev, kot je opredeljena v Prilogi V k navedeni direktivi.
France was designated as rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 17 March 2009 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Francija, ki je bila imenovana za državo članico poročevalko, je 17. marca 2009 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji poslala poročilo pristojnega organa in priporočilo.
In accordance with Article 15(4) of Regulation (EC) No 1451/2007, the findings of the review were incorporated, within the Standing Committee on Biocidal Products on 22 September 2011, in an assessment report.
V skladu s členom 15(4) Uredbe (ES) št. 1451/2007 so bile ugotovitve pregleda 22. septembra 2011 v Stalnem odboru za biocidne pripravke vključene v poročilo o oceni.
The assessment of risks to the environmental compartments of concern, carried out using a realistic approach, has demonstrated unacceptable effects for the aquatic compartment.
Pri oceni tveganj za prizadete dele okolja, ki je bila opravljena z uporabo realističnega pristopa, so se pokazali nesprejemljivi učinki za vodni ekosistem.
Furthermore, the characteristics of flufenoxuron render it persistent, liable to bioaccumulate and toxic, as well as very persistent and very liable to bioaccumulate, in accordance with the criteria laid down in Annex XIII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council [3].
Poleg tega je flufenoksuron zaradi svojih lastnosti obstojen, toksičen in se lahko kopiči v organizmih, obenem pa je v skladu z merili iz Priloge XIII k Uredbi (ES) št. 1907/2006 Evropskega parlamenta in Sveta [3] zelo obstojen in se zelo lahko kopiči v organizmih.
It is therefore not appropriate to include flufenoxuron for use in product type 18 in Annexes I, IA or IB to Directive 98/8/EC.
Zato flufenoksurona ni primerno vključiti za uporabo v 18. vrsti izdelkov v prilogah I, IA ali IB k Direktivi 98/8/ES.
The date as of which date biocidal products of product type 18 containing flufenoxuron should no longer be placed on the market should be reasonable with regard to the outcome of the risk assessment as well as the date of entry into force of this Decision..
Datum, od katerega se biocidni pripravki 18. vrste izdelkov z vsebnostjo flufenoksurona ne smejo več dajati v promet, mora biti sprejemljiv glede na rezultat ocene tveganj in glede na datum začetka veljavnosti tega sklepa.
Flufenoxuron (CAS No 101463-69-8; EC No 417-680-3) shall not be included in Annexes I, IA or IB to Directive 98/8/EC for product type 18.
Flufenoksuron (št. CAS 101463-69-8; št. ES 417-680-3) se za 18. vrsto izdelkov ne vključi v priloge I, IA ali IB k Direktivi 98/8/ES.
For the purposes of Article 4(2) of Regulation (EC) No 1451/2007, biocidal products of product type 18 containing flufenoxuron shall no longer be placed on the market with effect from 1 August 2012.
Za namene člena 4(2) Uredbe (ES) št. 1451/2007 se biocidni pripravki 18. vrste izdelkov z vsebnostjo flufenoksurona od 1. avgusta 2012 naprej ne dajejo več v promet.
For a number of substance/product type combinations included in that list, either all participants have discontinued their participation in the review programme, or no complete dossier was received within the time period specified in Articles 9 and 12(3) of Regulation (EC) No 1451/2007 by the Member State designated as rapporteur for the evaluation.
Za mnoge kombinacije snovi/vrst pripravkov, vključene v navedeni seznam, so se bodisi vsi udeleženci umaknili iz programa pregledovanja bodisi država članica, imenovana za poročevalko pri ocenjevanju, ni prejela celotne dokumentacije do roka iz člena 9 in člena 12(3) Uredbe (ES) št. 1451/2007.
Consequently, and pursuant to Articles 11(2), 12(1) and 13(5) of Regulation (EC) No 1451/2007, the Commission informed the Member States accordingly.
Zato je Komisija v skladu s členom 11(2), členom 12(1) in členom 13(5) Uredbe (ES) št. 1451/2007 o tem obvestila države članice.
Within the period of three months from those publications, a number of companies indicated an interest in taking over the role of participant for certain of the substances and product types concerned.
V treh mesecih po navedeni objavi je več družb izrazilo zanimanje za prevzem vloge udeleženca za nekatere zadevne snovi in vrste pripravkov.
Pursuant to Articles 12(4) and 12(5) of Regulation (EC) No 1451/2007, the substances and product types concerned should therefore not be included in Annexes I, IA or IB to Directive 98/8/EC.
Na podlagi člena 12(4) in (5) Uredbe (ES) št. 1451/2007 se zato zadevne snovi in vrste pripravkov ne vključijo v Prilogo I, IA ali IB k Direktivi 98/8/ES.
In the interest of legal certainty, it is appropriate to specify the date after which biocidal products of the product types listed in the Annex to this Decision containing the active substances listed in that Annex should no longer be placed on the market.
Zaradi pravne varnosti je primerno določiti datum, po katerem se biocidni pripravki iz vrst pripravkov iz Priloge k temu sklepu, ki vsebujejo aktivne snovi iz navedene priloge, ne bi smeli več dajati v promet.
The substances indicated in the Annex to this Decision shall not be included for the product types concerned in Annexes I, IA or IB to Directive 98/8/EC.
Snovi, navedene v Prilogi k temu sklepu, se za zadevne vrste pripravkov ne vključijo v priloge I, IA ali IB k Direktivi 98/8/ES.
For the purposes of Article 4(2) of Regulation (EC) No 1451/2007, biocidal products of the product types listed in the Annex to this Decision which contain the active substances listed in that Annex shall no longer be placed on the market with effect from 1 February 2013.
Za namene člena 4(2) Uredbe (ES) št. 1451/2007 se biocidni pripravki iz vrst pripravkov iz Priloge k temu sklepu, ki vsebujejo aktivne snovi iz navedene priloge, od 1. februarja 2013 dalje ne dajejo več v promet.
Substances and product types not to be included in Annexes I, IA or IB to Directive 98/8/EC
Snovi in vrste pripravkov, ki se ne vključijo v priloge I, IA ali IB k Direktivi 98/8/ES
A member’s seat on the Committee of the Regions has become vacant following the end of the electoral mandate on the basis of which Mr Markus WALLNER was appointed,
Po izteku volilnega mandata, na podlagi katerega je bil imenovan Markus WALLNER, se je v Odboru regij sprostilo mesto člana –
The following is hereby reappointed to the Committee of the Regions as member for the remainder of the current term of office, which runs until 25 January 2015:
Za preostanek mandata, ki se izteče 25. januarja 2015, se za člana Odbora regij ponovno imenuje:
Mr Markus WALLNER, Landeshauptmann von Vorarlberg (change of mandate).
Markus WALLNER, Landeshauptmann von Vorarlberg (sprememba mandata).
OJ L 107, 29.4.2010, p. 20.
UL L 107, 29.4.2010, str. 20.
On 26 April 2010, Mr Markus WALLNER was appointed as member until 25 January 2015 by Council Decision 2010/242/EU [3], following the end of the term of office of Mr Herbert SAUSGRUBER.
Po izteku mandata Herberta SAUSGRUBERJA je bil Markus WALLNER 26. aprila 2010 s Sklepom Sveta 2010/242/EU [3] imenovan za člana do 25. januarja 2015.
appointing four Czech members and four Czech alternate members of the Committee of the Regions
o imenovanju štirih čeških članov in štirih čeških nadomestnih članov Odbora regij
Four members’ seats on the Committee of the Regions have become vacant following the end of the terms of office of Mr Jiří BYTEL, Mr Jan KUBATA, Ms Helena LANGŠÁDLOVÁ and Mr Juraj THOMA.
Zaradi izteka mandata Jiříja BYTELA, Jana KUBATE, Helene LANGŠÁDLOVE in Juraja THOME so se sprostila štiri mesta članov Odbora regij.
Four alternate members’ seats on the Committee of the Regions have become vacant following the end of the terms of office of Ms Ivana ČERVINKOVÁ, Mr Tomáš CHALUPA, Ms Sylva KOVÁČIKOVÁ and Mr Tomáš ÚLEHLA,
Zaradi izteka mandata Ivane ČERVINKOVE, Tomáša CHALUPE, Sylve KOVÁČIKOVE in Tomáša ÚLEHLE so se sprostila štiri mesta nadomestnih članov Odbora regij –
Mr Juraj THOMA, primátor statutárního města Českých Budějovic (change of mandate);
Juraj THOMA, primátor statutárního města Českých Budějovic (sprememba mandata)
Ms Sylva KOVÁČIKOVÁ, zastupitelka města Bílovec (change of mandate),
Sylva KOVÁČIKOVÁ, zastupitelka města Bílovec (sprememba mandata)
OJ L 348, 29.12.2009, p. 22.
UL L 348, 29.12.2009, str.22.
authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean A5547-127 (ACS-GMØØ6-4) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
o odobritvi dajanja na trg proizvodov, ki vsebujejo gensko spremenjeno sojo A5547-127 (ACS-GMØØ6-4), so iz nje sestavljeni ali proizvedeni, v skladu z Uredbo (ES) št. 1829/2003 Evropskega parlamenta in Sveta
On 31 March 2008, Bayer CropScience AG submitted to the competent authority of the Netherlands an application, in accordance with Articles 5 and 17 of Regulation (EC) No 1829/2003, for the placing on the market of foods, food ingredients, and feed containing, consisting of, or produced from A5547-127 soybean (‘the application’).
Družba Bayer CropScience AG je 31. marca 2008 v skladu s členoma 5 in 17 Uredbe (ES) št. 1829/2003 pri pristojnemu organu Nizozemske vložila vlogo za dajanje na trg živil, živilskih sestavin in krme, ki vsebujejo sojo A5547-127, so iz nje sestavljeni ali proizvedeni (v nadaljnjem besedilu: vloga).
The application also covers the placing on the market of products other than food and feed containing or consisting of A5547-127 soybean for the same uses as any other soybean with the exception of cultivation.
Vloga zajema tudi dajanje na trg drugih proizvodov, ki niso živila in krma ter vsebujejo sojo A5547-127 ali so iz nje sestavljeni, za enako uporabo kot katera koli druga vrsta soje, razen za gojenje.
On 10 May 2011, the European Food Safety Authority (EFSA) gave a favourable opinion in accordance with Articles 6 and 18 of Regulation (EC) No 1829/2003.
(3) Evropska agencija za varnost hrane (v nadaljnjem besedilu: EFSA) je 10. maja 2011 dala ugodno mnenje v skladu s členoma 6 in 18 Uredbe (ES) št. 1829/2003.
It concluded that soybean A5547-127, as described in the application, is as safe as its non-genetically modified counterpart with respect to potential effects on human and animal health or the environment [3].
Menila je, da je soja A5547-127, opisana v vlogi, enako varna kot gensko nespremenjena soja glede možnih učinkov na zdravje človeka in živali ali okolje [3].
In its opinion, EFSA considered all the specific questions and concerns raised by the Member States in the context of the consultation of the national competent authorities as provided for by Articles 6(4) and 18(4) of that Regulation.
EFSA je v mnenju preučila vsa posebna vprašanja in pomisleke držav članic iz posvetovanja s pristojnimi nacionalnimi organi v skladu s členom 6(4) in členom 18(4) navedene uredbe.
In particular, EFSA concluded that soybean A5547-127 is compositionally and agronomically not different from its non-genetically modified counterpart and equivalent to commercial varieties, except for the introduced trait and as a consequence, that animal safety studies with the whole food/feed (e.g. a 90-day toxicity study in rats) are not needed.
EFSA je predvsem ugotovila, da se soja A5547-127 po sestavi in agronomskih lastnostih ne razlikuje od gensko nespremenjene soje in da je enakovredna komercialnim sortam, od njih se razlikuje le po dodani lastnosti, ter da zato študije o varnosti pri živalih na celotnih živilih/krmi (npr. 90-dnevne študije o toksičnosti pri podganah) niso potrebne.
Taking into account those considerations, authorisation should be granted for the products containing, consisting of, or produced from A5547-127 soybean as described in the application (‘the products’).
Ob upoštevanju navedenih vidikov je treba odobriti proizvode, ki vsebujejo sojo A5547-127, so iz nje sestavljeni ali proizvedeni, kot so opisani v vlogi („proizvodi“).
On the basis of the EFSA opinion, no specific labelling requirements other than those provided for in Articles 13(1) and 25(2) of Regulation (EC) No 1829/2003, appear to be necessary for foods, food ingredients and feed containing, consisting of, or produced from A5547-127 soybean.
Na podlagi mnenja EFSA za živila, živilske sestavine in krmo, ki vsebujejo sojo A5547-127, so iz nje sestavljeni ali proizvedeni, niso potrebne nobene posebne zahteve za označevanje, razen tistih iz člena 13(1) in člena 25(2) Uredbe (ES) št. 1829/2003.
However, in order to ensure the use of the products within the limits of the authorisation provided for by this Decision, the labelling of feed containing or consisting of the GMO and products other than food and feed containing or consisting of the GMO for which authorisation is requested should be complemented by a clear indication that the products in question must not be used for cultivation.
Da se zagotovi uporaba proizvodov v mejah odobritve iz tega sklepa, pa je treba pri označevanju krme, ki vsebuje GSO ali je iz njega sestavljena, ter drugih proizvodov, ki niso živila in krma ter vsebujejo GSO ali so iz njega sestavljeni in za katere je bila vložena vloga za odobritev, jasno navesti, da se zadevni proizvodi ne smejo uporabljati za gojenje.
This Decision is to be notified through the Biosafety Clearing House to the Parties to the Cartagena Protocol on Biosafety to the Convention on Biological Diversity, pursuant to Article 9(1) and point (c) of Article 15(2) of Regulation (EC) No 1946/2003 of the European Parliament and of the Council of 15 July 2003 on transboundary movements of genetically modified organisms [7].
O tem sklepu je treba prek Urada za izmenjavo informacij o biološki varnosti obvestiti podpisnice Kartagenskega protokola o biološki varnosti h Konvenciji o biološki raznovrstnosti v skladu s členom 9(1) in členom 15(2)(c) Uredbe (ES) št. 1946/2003 Evropskega parlamenta in Sveta z dne 15. julija 2003 o čezmejnem gibanju gensko spremenjenih organizmov [7].
An implementing act was deemed to be necessary and the chair submitted the draft implementing act to the appeal committee for further deliberation.
Potreben je bil izvedbeni akt in predsednik je predložil osnutek izvedbenega akta Odboru za pritožbe v nadaljnjo razpravo.
The appeal committee did not deliver an opinion,
Odbor za pritožbe ni predložil mnenja –
Genetically modified soybean A5547-127, as specified in point (b) of the Annex to this Decision, is assigned the unique identifier ACS-GMØØ6-4, as provided for in Regulation (EC) No 65/2004.
Gensko spremenjeni soji A5547-127, kakor je opredeljena v točki (b) Priloge k temu sklepu, se dodeli posebni identifikator ACS-GMØØ6-4 v skladu z Uredbo (ES) št. 65/2004.
foods and food ingredients containing, consisting of, or produced from ACS-GMØØ6-4 soybean;
živila in živilske sestavine, ki vsebujejo sojo ACS-GMØØ6-4, so iz nje sestavljeni ali proizvedeni;
feed containing, consisting of, or produced from ACS-GMØØ6-4 soybean;
krma, ki vsebuje sojo ACS-GMØØ6-4, je iz nje sestavljena ali proizvedena;
products other than food and feed containing or consisting of ACS-GMØØ6-4 soybean for the same uses as any other soybean with the exception of cultivation.
proizvodi, ki niso živila in krma ter vsebujejo sojo ACS-GMØØ6-4 ali so iz nje sestavljeni, za enako uporabo kot katera koli druga vrsta soje, razen za gojenje.
For the purposes of the labelling requirements laid down in Article 13(1) and Article 25(2) of Regulation (EC) No 1829/2003 and in Article 4(6) of Regulation (EC) No 1830/2003, the ‘name of the organism’ shall be ‘soybean’.
Za namene zahtev za označevanje iz člena 13(1) in člena 25(2) Uredbe (ES) št. 1829/2003 ter člena 4(6) Uredbe (ES) št. 1830/2003 je „ime organizma“„soja“.
The words ‘not for cultivation’ shall appear on the label of and in documents accompanying products containing or consisting of ACS-GMØØ6-4 soybean referred to in points (b) and (c) of Article 2.
Besede „ni za gojenje“ se navedejo na oznakah proizvodov in v dokumentih, priloženih k proizvodom, ki vsebujejo sojo ACS-GMØØ6-4 ali so iz nje sestavljeni in so navedeni v členu 2(b) in (c) tega sklepa.
The authorisation holder shall submit to the Commission annual reports on the implementation and the results of the activities set out in the monitoring plan in accordance with the Decision 2009/770/EC.
Imetnik odobritve v skladu z Odločbo 2009/770/ES Komisiji predloži letna poročila o izvajanju in rezultatih dejavnosti iz načrta spremljanja.
The information set out in the Annex to this Decision shall be entered in the Community register of genetically modified food and feed, as provided for in Article 28 of Regulation (EC) No 1829/2003.
Podatki iz Priloge k temu sklepu se vnesejo v register Skupnosti za gensko spremenjena živila in krmo v skladu s členom 28 Uredbe (ES) št. 1829/2003.
The authorisation holder shall be Bayer CropScience AG.
Imetnik odobritve je družba Bayer CropScience AG.
This Decision is addressed to Bayer CropScience AG, Alfred-Nobel-Strasse 50, 40789 Monheim am Rhein, GERMANY
Ta sklep je naslovljen na družbo Bayer CropScience AG, Alfred-Nobel-Strasse 50, 40789 Monheim am Rhein, NEMČIJA
Address Alfred-Nobel-Strasse 50, 40789 Monheim am Rhein, GERMANY
Naslov Alfred-Nobel-Strasse 50, 40789 Monheim am Rhein, NEMČIJA
Foods and food ingredients containing, consisting of, or produced from ACS-GMØØ6-4 soybean.
Živila in živilske sestavine, ki vsebujejo sojo ACS-GMØØ6-4, so iz nje sestavljeni ali proizvedeni,
Feed containing, consisting of, or produced from ACS-GMØØ6-4 soybean.
krma, ki vsebuje sojo ACS-GMØØ6-4, je iz nje sestavljena ali proizvedena,
Products other than food and feed containing or consisting of ACS-GMØØ6-4 soybean for the same uses as any other soybean with the exception of cultivation.
proizvodi, ki niso živila in krma ter vsebujejo sojo ACS-GMØØ6-4 ali so iz nje sestavljeni, za enako uporabo kot katera koli druga vrsta soje, razen za gojenje.
The genetically modified ACS-GMØØ6-4 soybean, as described in the application, expresses the PAT protein which confers tolerance to the glufosinate-ammonium herbicide.
Gensko spremenjena soja ACS-GMØØ6-4, kakor je opisana v vlogi, izloča beljakovino PAT, zaradi katere je odporna na herbicid glufosinat-amonij.
For the purposes of the specific labelling requirements laid down in Article 13(1) and Article 25(2) of Regulation (EC) No 1829/2003, and in Article 4(6) of Regulation (EC) No 1830/2003, the ‘name of the organism’ shall be ‘soybean’.
Za namene posebnih zahtev za označevanje iz člena 13(1) in člena 25(2) Uredbe (ES) št. 1829/2003 ter člena 4(6) Uredbe (ES) št. 1830/2003 je „ime organizma“„soja“;